Cartesian Therapeutics, Inc. — Director's Dealing 2018

Jun 20, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2018-06-15

Reporting Person: Leaman John Harold (CFO, Treas. & Hd Corp Strategy)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-15	Stock Option (right to buy)	$12.75	A	50000	Acquired	2028-06-14	Common Stock (50000)	Direct

Footnotes

F1: The option will vest as to 25% of the shares on June 15, 2019. The remainder of the shares will vest in 36 equal monthly installments thereafter.